Dedicated to helping you navigate the difficult waters of health care editorial content and consulting.
SM Health Communications provides an array of expertise in medical/health care writing and editing. Our writers have covered the entire spectrum, from highly technical clinical issues, health policy research and reviews, payer markets, and news features geared to the lay public.
Specializing in the payer markets, we provide in-depth telephone interviews, comprehensive Web-based surveys, and tools to help you get the answers you need for key decision makers as quickly and cost effectively as possible. Ask us about our unique market research products to meet your immediate market access challenges.
Before launch and even postlaunch, the biopharmaceutical, device, and diagnostics industries need business intelligence on whether their product’s value proposition and market positioning will result in advantaged, disadvantaged, or parity placement compared with that of their competitors. Our mock P&T Committee capabilities will cost effectively and reliably fill in the blanks — this is an outcomes test of your payer markets access strategy!
Have a meeting that you need covered and converted to a monograph? Have a meeting that you want to hold but don’t know how to get started in reaching your audience? SM Health Communications has the answers and expertise to turn that symposium or clinical track into a marketable monograph, distributed to a customizable group of audiences. SM Health Communications can connect your monograph to a recognized publication with the distribution to meet your needs!
Now Available from SM Health Communications
What our clients are saying…
I have had the pleasure of working with Stan Mehr on several client projects over the past several years. Stan is a consummate professional and Market Access subject matter expert. He has brought valuable insights and well-tuned perspectives to all of our engagements. He has clearly demonstrated the strong ability to flex based on client needs and changing priorities. As a trusted partner, Stan has built enduring relationships with our team and our clients. I sincerely hope to have the opportunity to work with Stan again.
SVP, Market Access
SM Health Communications has been a consistent go-to resource for me to gain market access insights. I am an account VP for a marketing agency and support several large pharmaceutical companies on new drug launches and strategies for continued growth of their existing product portfolios. In this everchanging market access space, it is imperative to understand the evolving PBM and payer space in order to provide strategic direction to my clients.
Stan has been an invaluable resource to me over the last several years. He keeps me and my teams informed of recent market developments including PBM/payer consolidation, new regulations, and he has a keen understanding of the specialty drug and biosimilar market landscape. He is also extremely reliable during tight timelines. If you are looking for market access, specialty drug or biosimilar expertise, I highly recommend SM Health Communications.
The Kinetix Group
Featured from our Discussions, helpful information on the payer markets!
With the announcement of the first drugs subject to the IRA in 2026, the drug industry filed lawsuits to prevent CMS from implementing the program. Their only true motivation is to forestall loss of revenue on lucrative products, not preventing future innovation.
I’ve written about aspects of the patient journey in the past, and one thorny difficulty is the problem of inappropriate claim denials. Note, I used the word “difficulty” here, not “challenge” because there is no need for diplomacy here. When someone is seriously ill...